Coronel CC

Language: Spanish
References: 32
Page: 221-225
PDF size: 57.41 Kb.

ABSTRACT

Objective. Determine effectiveness of the disodium cromoglycate in the treatment of the asthma exacerbation.
Material and methods. A comparative investigation in 170 children under 15 years, who were treated by suffered some episode of asthma exacerbation was done. They were divided in two groups: the group A was treated with cromoglycate and the B with steroids.
Results. Obtained in both group of treatment were compared. Results. The average age was 7.8 years in the group A and 6.2 years in the B. The cromoglycate inhaled was effective in the 88.6% of the mild exacerbation and the 73.3% of the moderate. The exacerbation had a duration of 65.3% hours in the patients from group A and 63.1 hours in those group B. The treatment failed in the 14.1% from group A and the 10.6% from group B.
Conclusions. The cromoglycate was as effective as steroids in the treatment of the asthma bronchial exacerbation.

REFERENCES

1. Álvarez R, Álvarez R, Fernández E, Peraza JL. Mediadores inflamatorios y asma bronquial. Rev Cubana Med Gen Integr 1994; 11(2): 176-9.

2. Álvarez R, Álvarez R, Fernández E, Rodríguez F. Mediadores inflamatorios en el asma. Rev Cubana Med Gen Integr 1995; 11(2): 168-71.

3. González E, Garmendia A, Mintegui J, Callen M, Albisú Y, Rubio E. Tratamiento crónico del asma leve con antiinflamatorios inhalados. Ann Esp Pediatr 1994; 41(2): 102-6.

4. Sienra JJ, Baeza MA, Serrano A. Tratamiento del asma. Bol Med Hosp Infant Mex 1995; 52(7): 443-50.

5. Expert Panel Report 2: Guidelines from the diagnosis and management of asthma. Bethesda (MD): National Asthma Education and Prevention Program, National Institutes of Health; 1997. Report No. NHI-97-4051 A.

6. Álvarez R, Álvarez R, Álvarez M. Broncodilatadores en el tratamiento del asma crónica. Rev Cubana Med Gen Integr 1995; 11(4): 375-77.

7. Álvarez R, Álvarez R, Díaz G, Rivero H. Xantinas en el asma: ascenso o descenso? Rev Cubana Med Gen Integr 1995; 11(4): 349-53.

8. Shapiro GG. Steroids and asthma. Pediatr 1995; 96(2): 347-8.

9. Creticos P, Burk J, Smith L, Comp R, Norman P, Findlay S. The use of twice daily nedocromil sodium in the treatment of asthma. J Allergy Clin Immunol 1995; 95: 829-36.

10. Bustos GJ, Baena CE, Minervini MC, Saranz R. Asma bronquial en niños y adolescentes. Actualización en diagnóstico y tratamiento. Arch Arg Pediatr 1994; 92: 37-46.

11. Cloutier MM. Pulmonary diseases. In: Deworkin PH. Pediatrics. 3rd edition. Connecticut: Williams & Wilkins. 1997: 400-5.

12. Hernández CF. Comportamiento del asma bronquial infantil en la atención primaria. Rev Cubana Med Gen Integr 1994; 10(4): 351-6.

13. Martínez FD, Wright AL, Tanssing LM, Holbreg CJ, Halonen M, Moregan WJ et al. Asthma and wheezing in the first six years of life. The New England Journal of Medicine 1995; 332(3): 133-8.

14. Maldonado ML, Linares FJ, del Río BE, Sienra JJL. Comparación entre salbutamol administrado por inhaladores de dosis medida con espaciador vs nebulizado en niños con asma aguda. Bol Med Hosp Inf Mex 1997; 54(8): 374-8.

15. Álvarez R. Beta agonistas y asma. Rev Cubana Med Gen Integr 1994; 10(4): 405-6.

16. Álvarez R. Beta 2 agonistas y linfocitos. Rev Cubana Med Gen Integr 1994; 10(4): 403-4.

17. Edwards T, Dockhorn RJ, Wagner DE, Fiddes RA, Grossman J, Menendez R et al. Efficacy of once daily extended-release theophylline in decreasing the salbutamol the use of inhaled B2 agonists in stable, mild to moderate asthma patients. Ann Allergy Asthma & Immunology 1995; 75: 409-16.

18. Kannisto S, Korppi M, Remes K, Vontilainen R. Adrenal suppression evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab 2000; 85(2): 652-7.

19. Krawiec ME, Wenzel SE. Inhaled nonsteroidal anti-inflammatory medications in the treatment of asthma. Resp Care Clin N Am 1999; 5(4): 555-74.

20. Mencol E, Drovet M, Sabat A. Membrane stabilizers. Allerg Immunol 1999; 3(4): 103-5.

21. Matsuo N, Shimoda T, Matsuse H, Obase Y, Asai S, Khono S. Effects of sodium cromoglycate on cytokine production following antigen stimulation of a passively sensitized human lung model. Ann Allergy Asthma Immunol 2000; 84(1): 72-8.

22. Jahnova E, Harvatova M, Gazdik F. Expression of adhesion molecules and effect of sodium cromoglycate in asthmatics. Physiol Resp 1998; 47(6): 439-43.

23. Harvathova M, Podivinsky F, Gazdik F, Jahnova E. Effect of disodium cromoglycate treatment on peripheral blood mononuclear cell adhesion to cultured endothelium in allergic asthmatic. Physiol Resp 1998; 47(6): 445-51.

24. Matsuse H, Matsuo N, Shimoda T, Obase Y, Asai S, Khono S et al. Sodium cromoglycate inhibits antigen induced cytokine production by peripheral blood mononuclear cells from atopic asthmatic in vitro. Ann Allergy Asthma Immunol 1999; 83(6): 511-5.

25. Vizel AA, Khabibullin KA. Comparative effect of acute test using ventolin, ventodisk and intal plus in the ambulatory pulmonological practice. Probl Tuberk 1999; 2: 35-7.

26. Milgron H, Tausing LM. Keeping children with exercise-induced asthma active. Pediatrics 1999; 104(3): 3-8.

27. Nathan RA, Minkwitz MC, Bonacelli CM. Two first line therapies in the treatment of mild asthma: use of peak flow variability as a predictor of effectiveness. Ann Allergy Asthma Immunol 1999; 82(5): 497-503.

28. Volovitz B, Tabachnik E, Nussinovitch M, Shtaif B, Blau H, Gil I et al. Montelukast a leucotriene receptor antagonist reduce the concentration of leucotrienes in the respiratory tract of children with persistent asthma. J Allergy Clin Immunol 1999; 104(6): 1162-7.

29. Sekerel BE, Saraclar Y, Etikan I, Kalayci O. Comparison of two different dose regimens of nedocromil sodium with placebo in the management of childhood asthma. J Investig Allergol Clin Immunol 1999; 9(5): 293-8.

30. Furukawa C, Atkinson D, Forster JJ, Nazario K, Simpson B, Uriniack T et al. Controlled trial of two formulations of cromoglyn sodium in the treatment of asthmatic patients. Chest 1999; 116(1): 65-72.

31. Kato Y, Muraki K, Fujitaka M, Sakuva N, Ueda K. Disodium cromoglycate use in children and adolescents with asthma: correlation between plasma concentrations and protective effects for various inhalation methods. Ann Allergy Asthma Immunol 1999; 83(6): 553-8.

32. Kato Y, Muraki K, Fujitaka M, Sakura N, Ueda K. Plasma concentrations of disodium cromoglycate after various inhalations methods subjects. Br J Clin Pharmacol 1999; 48(2): 154-7.